Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29860938

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Jun 21
First author
DiNardo CD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Aug;15(8):472. doi: 10.1038/s41571-018-0057-4.
    note
    Source null
    related pmid
    29925981
    relationship
    Comment in
  2. citation
    Cancer Discov. 2018 Aug;8(8):OF1. doi: 10.1158/2159-8290.CD-NB2018-082.
    note
    Source null
    related pmid
    29934313
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Sep 20;379(12):1186. doi: 10.1056/NEJMc1809507.
    note
    Source null
    related pmid
    30260154
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Sep 20;379(12):1186. doi: 10.1056/NEJMc1809507.
    note
    Source null
    related pmid
    30260155
    relationship
    Comment in

Authors and identifiers

  1. name
    DiNardo CD
    type
    Author
  2. name
    Stein EM
    type
    Author
  3. name
    de Botton S
    type
    Author
  4. name
    Roboz GJ
    type
    Author
  5. name
    Altman JK
    type
    Author
  6. name
    Mims AS
    type
    Author
  7. name
    Swords R
    type
    Author
  8. name
    Collins RH
    type
    Author
  9. name
    Mannis GN
    type
    Author
  10. name
    Pollyea DA
    type
    Author
  11. name
    Donnellan W
    type
    Author
  12. name
    Fathi AT
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    DiNardo CD
    type
    Author
  2. name
    Stein EM
    type
    Author
  3. name
    de Botton S
    type
    Author
  4. name
    Roboz GJ
    type
    Author
  5. name
    Altman JK
    type
    Author
  6. name
    Mims AS
    type
    Author
  7. name
    Swords R
    type
    Author
  8. name
    Collins RH
    type
    Author
  9. name
    Mannis GN
    type
    Author
  10. name
    Pollyea DA
    type
    Author
  11. name
    Donnellan W
    type
    Author
  12. name
    Fathi AT
    type
    Author
bibliography ids
  1. nci-bib-5a6732bb3d90509a46fc44ec
book metadata
content sha256
11ea52ff446a480bf9b9214f05d938c97b281a3d90d23c899a405b3c715fd1e4
document type
citation
dois
  1. 10.1056/NEJMoa1716984
electronic publication date
display
2018 Jun 2
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29860938
immutable id
pubmed:29860938@11ea52ff446a480bf9b9214f05d938c97b281a3d90d23c899a405b3c715fd1e4
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
25
name
The New England journal of medicine
nlm unique id
0255562
pages
2386-2398
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Aug;15(8):472. doi: 10.1038/s41571-018-0057-4.
    note
    Source null
    related pmid
    29925981
    relationship
    Comment in
  2. citation
    Cancer Discov. 2018 Aug;8(8):OF1. doi: 10.1158/2159-8290.CD-NB2018-082.
    note
    Source null
    related pmid
    29934313
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Sep 20;379(12):1186. doi: 10.1056/NEJMc1809507.
    note
    Source null
    related pmid
    30260154
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Sep 20;379(12):1186. doi: 10.1056/NEJMc1809507.
    note
    Source null
    related pmid
    30260155
    relationship
    Comment in
outcomes validated
false
pmid
29860938
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
eb4c80647de2e702c695112cbda476ad8feafe8a21e637da5b075f90e6c1f400
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jun 21
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29860938/
title
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

Preserved source evidence · Not medical advice